Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Understanding the mechanism helps set realistic expectations for what an injectable protocol is doing versus what marketing sometimes implies
Early research and expert summaries suggest it may promote tissue regeneration by improving circulation in damaged areas
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
BPC-157 (Body Protection Compound-157) Purported Benefits: Accelerated wound healing Reduced inflammation Improved joint and gut health Potential Risks and Complications: Unknown Long-Term Effects: With limited human studies, the long-term impact on organs and systems is unknown
US$ 22.82
US$ 23.85
US$ 28.34
US$ 20.20
US$ 22.51
US$ 21.11
US$ 28.20
